Mobile Menu
In Case You Missed It

In Case You Missed It

  • Ask The Nursing Expert

    In a June 6, 2016 article in McKnight’s, Angel McGarrity-Davis, RN, CDONA, NHA shares her experiences, insights and inspiration as a director of nursing new to long-term care.  McKnight’s article.

  • FDA Suggests Further Limiting Use of Fluoroquinolones

    In 2016 the U.S. Food and Drug Administration (FDA) announced in a Drug Safety Communication that prescribers should limit use of systemic fluoroquinolone antibiotics to only situations where alternative treatment options are unavailable for certain infections. This FDA announcement follows a safety review that showed a significant risk of “disabling and potentially permanent serious side effects” involving tendons, muscles, joints, and nerves. Individuals prescribed fluoroquinolones should be closely monitored for tendon, joint and/or muscle pain, a tingling or pricking sensation, confusion, and/or hallucinations.

    Read More
  • McKnight’s Long-Term Care News

    McKnight’s Long-Term Care News recently posted an article on “Shifting policy, care demands impacting SNF (skilled nursing facility) occupancy rates.”  They share that a “demand for more specialized care and an evolving policy environment could be behind a decrease in nursing home occupancy rates, according to an expert with the National Investment Center for Seniors Housing & Care.” To read more, visit SNF occupancy rates.

For more news and information about our industry, please visit the websites below:

Contact us today at 844-637-9461 (844-MERWIN1) or info@MerwinLTC.com to learn how we help revitalize the patient experience.